Bio-Path Holdings, Inc. Skyrocketed
Mon, Jun 03, 2024 at 07:20 PM
Bio-Path Holdings, Inc. (BPTH:NASDAQ) rocketted at $3.23, a gain of 56.8%. On Mon, Jun 03, 2024, BPTH:NASDAQ touched a New 2-Week High of $3.23. The stock got featured on our News Catalysts scanner on Mon, Jun 03, 2024 at 10:32 AM in the 'BIOTECH' category. From Mon, May 20, 2024, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Mon, Jun 03, 2024 at $4.55 with a volume of 56M+.
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- Avalon GloboCare Corp. (ALBT:NASDAQ), 316.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 100%
- Hywin Holdings Ltd. (HYW:NASDAQ), 91.19%
- Affimed N.V. (AFMD:NASDAQ), 68.51%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 61.29%
- Concord Medical Services Holdings Limited (CCM:NYSE), 57.99%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 56.8%
- Structure Therapeutics Inc. (GPCR:NASDAQ), 54.21%
- Histogen Inc. (HSTO:NASDAQ), 45.35%
- Power REIT (PW:NYSEMKT), 39.1%